Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @aimmune
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @aimmune
-
The continued investment from
@NestleHealthUS announced today supports our mutual goal of developing innovative therapies for#foodallergies. Read our full release here: http://bit.ly/2v2dR21 pic.twitter.com/0g8hT0RLzv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today’s announcement is an exciting step toward further evolving the therapeutic landscape of
#foodallergy treatments. Read more here: http://bit.ly/2tw9mfH pic.twitter.com/iQupPhoVEq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We also greatly appreciate the critical work by all RAMSES physician investigators and their staff – thank you for your support
#peanutallergypic.twitter.com/914ZE0eD77Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to all of the PALISADE physician investigators and their staff who worked tirelessly to help get us to this approval
#peanutallergypic.twitter.com/AuZGmSb0AiPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We want to recognize the enormous amount of effort from groups like
@FoodAllergy,@AAAAI_org,@ACAAI,@AllergyAsthmaHQ and@AAFANational, whose advocacy and collaboration have been instrumental in supporting the FDA approval of the first#peanutallergy treatment.Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We also want to acknowledge the more than 1,200 patients and their families who participated in our clinical trials. Thank you for your support – without you, this FDA-approval would not have been possible!
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to all Aimmune employees for your incredible work leading up to this FDA-approval! Your dedication has helped bring this important treatment option to patients and their families.pic.twitter.com/geOri0v3LB
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BREAKING NEWS: We’re proud to announce FDA approval of the first treatment for
#peanutallergy. Read our release https://bwnews.pr/2GGIWen and the full Prescribing Information, including Boxed WARNING, and Medication Guide: http://bit.ly/36NgEJJ pic.twitter.com/Po2wbsDKALPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We look forward to participating in this year's CICBAA Symposium this weekend in Brussels, Belgium. For those attending, be sure to stop by our booth to meet the Aimmune team.
#foodallergypic.twitter.com/oRckSmJXQX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Another great year at
#JPM20 in the books! Our team looks forward to continued progress and innovation throughout 2020.pic.twitter.com/SPGff1kiIw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join us this afternoon to hear CEO Jayson Dallas speak at
#JPM20pic.twitter.com/XaDgk5gUpu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Heading to
#JPM20 – looking forward to presenting on Monday! See you there.pic.twitter.com/tsuYITlkc2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The number of children living with a
#peanutallergy continues to increase each year. Our team remains committed to providing treatment options for families affected. Learn more: http://bit.ly/2Zfvkhd pic.twitter.com/laOZZgKYTHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wishing you and your families a
#HappyNewYear! We look forward continuing our work for patients and families with#foodallergies in the new year.pic.twitter.com/DnZdUeGqMg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy Holidays from all of us at Aimmune! We wish you and your families a joyous season.pic.twitter.com/IOhlmMF1Om
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Traveling internationally this holiday season? Don't forget regulations around food labels vary country to country. Find tips for managing
#foodallergies while on vacation via@AAAAI http://bit.ly/2se9RtT pic.twitter.com/YPj3kXj4n0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Holiday parties are a time of joy and celebration, but can be difficult to navigate when you have a
#foodallergy. Read tips on how to stay safe during the holidays from@kfatweets: http://bit.ly/2RTp26L pic.twitter.com/whmehaMKL0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today is the start of the
@worldallergy Annual Congress in Lyon, France. Stop by our booth to learn more about our research on#foodallergies http://bit.ly/2E5rgHYHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It's the start of the NAPPA Congress in Sylt, Germany where future treatments for pediatric food allergy will be discussed. Stop by the Aimmune booth to meet our local team! http://bit.ly/34IoEv0
#foodallergyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Trying a new restaurant abroad? Chef cards are a helpful way to communicate foods that must be avoided due to
#foodallergy. Download cards from@FoodAllergy here: http://bit.ly/2QwKY6W pic.twitter.com/gJdqJ6P5YdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.